Study protocol for a cross-sectional study on knowledge, attitude, and practice towards thalassemia among Indonesian youth

Muhammad Maulana Wildani; Visabella Rizky Triatmono; Edward Christopher Yo; Mikhael Yosia; Pustika Amalia Wahidiyat

doi:10.1101/2021.04.11.21255264

ABSTRACT

Introduction Thalassemia is an inherited hemoglobinopathy with high prevalence and incidence in Indonesia. It leads to health, psychosocial, and economic burdens that affect patients, caregivers, and the country. As treatments for thalassemia in Indonesia remain expensive, not readily available, or associated with poor compliance, thalassemia prevention through screening programs is highly recommended to reduce the number of new cases. It is best to target thalassemia prevention and education to youth, but baseline data regarding their knowledge, attitude, and practice must first be assessed to measure their current awareness level as well as behavioral patterns regarding thalassemia. Currently, there has been limited research on public perception towards thalassemia in Indonesia.

Methods and analysis This observational, cross-sectional study will recruit at least 500 participants between the age of 15 - 24 across all provinces in Indonesia. This is the first nationwide thalassemia study that explores knowledge, attitude, and practice among Indonesian youth (15 - 24 years old) – including thalassemia major patients, carriers, unaffected individuals, and individuals with unknown carrier status. A questionnaire will be disseminated online through social media. The questionnaire will consist of 28 questions to assess knowledge, attitude, and practice from the general population and 38 questions to assess knowledge, attitude, and practice specifically from thalassemia major patients. Questions about whether thalassemia is perceived as a curse, role of consanguinity on the mode of inheritance, and willingness to undergo screening are incorporated to specifically suit Indonesian sociocultural settings.

Ethics and dissemination This study has been approved by the Ethical Committee of Faculty of Medicine, Universitas Indonesia, and Cipto Mangunkusumo Hospital. Informed consent will be obtained from all participants before completing the online questionnaire. Results will be published in a relevant journal and scientific meetings as well as shared with local stakeholders and policymakers.

Study registration This study has been registered at ClinicalTrials.gov (NCT04706585).

Strengths and limitations of this study

First nationwide knowledge, attitude, and practice study on Indonesian youth that provides baseline data for thalassemia major patients, carriers, unaffected individuals, and individuals with unknown carrier status.
Incorporation of knowledge, attitude, and practice questions that are specific to Indonesian cultural settings, which include perception of thalassemia as a curse and impact of consanguinity on inheritance of thalassemia.
Online dissemination of the survey via social media allows us to reach a large number of Indonesian youth from all backgrounds who are located in all 34 provinces of Indonesia
The use of online self-administered questionnaire for data collection may discourage those with poor Internet connection, particularly in remote areas, from participating.
Lack of background data on public perception towards thalassemia in Indonesia means that some assumptions from expert opinions and educated guesses have to be made when developing the questionnaire.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04706585

Funding Statement

No external funding recieved

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical Committee of Faculty of Medicine, Universitas Indonesia, and Cipto Mangunkusumo Hospital (KET-1517/UN2.F1/ETIK/PPM.00.02/2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

Simplified ClinicalTrial.gov registry information; Change author list; Change Gantt chart to address postponement of recruitment to June-July 2021; Change anticipated recruitment date to June 2021